Researchers Identify Antibacterial Protein in Tilapia Gut
Scientists isolated a potential antimicrobial agent from gut bacteria in tilapia to help reduce reliance on aquaculture antibiotics.
Updated on Oct. 23, 2026 in Life Sciences
Researchers discovered a protease-sensitive antibacterial substance produced by Enterobacter ludwigii isolated from the gut of a healthy tilapia. Genetic analysis revealed a 162-amino-acid colicin V-like protein candidate that serves as the potential determinant for this antibacterial activity.
Why it matters
Fish-associated intestinal bacteria are being investigated as natural sources of antimicrobial compounds. Identifying these substances could help reduce the aquaculture industry's current reliance on conventional antibiotics.
The active bacterial isolate features a 4.96-Mb draft genome with 54.31% GC content and 98.8048% average nucleotide identity to the known species type strain. The extracted active fraction demonstrated specific inhibitory activity against both Listeria monocytogenes and Aeromonas hydrophila.
The players
Enterobacter ludwigii
This is a species of bacteria often found in diverse environments that researchers identified as the source of the antibacterial substance in this study.
The details
After screening 64 intestinal bacterial isolates, scientists identified isolate A1, which showed significant antibacterial properties in its cell-free supernatant. The active fraction was enriched using ammonium sulfate precipitation and dialysis, though treatment with trypsin and proteinase K completely abolished the antibacterial effect.
Timeline
October 23, 2026: Research article publication.
The Big Picture
This discovery contributes to the ongoing search for alternatives to conventional aquaculture antibiotics by identifying a specific protein candidate. The finding shifts the focus toward utilizing fish-associated bacteria as a viable strategy to manage microbial threats in farmed species.
This breakthrough could lead to the development of new, natural antimicrobial treatments that decrease the use of traditional drugs in commercial fish farming. Such advancements may eventually result in cleaner aquaculture practices and reduced antibiotic residue in consumer seafood products.
The takeaway
Natural alternatives found within the gut microbiome of fish offer a promising path to sustainable disease management in aquaculture. Researchers continue to look for ways to isolate and utilize these specific bacterial proteins to replace broader, less targeted chemical treatments.
Further reading
Learn more about the latest developments in Life Sciences.
Source note: This article includes information reported by Nature.
